Literature DB >> 29294102

Increased Resting Hippocampal and Basal Ganglia Perfusion in People at Ultra High Risk for Psychosis: Replication in a Second Cohort.

Paul Allen1,2, Matilda Azis2, Gemma Modinos2, Matthijs G Bossong2,3, Ilaria Bonoldi2, Carly Samson2, Beverly Quinn4, Matthew J Kempton2, Oliver D Howes2, James M Stone2,5, Maria Calem2, Jesus Perez4, Sagnik Bhattacharayya6, Matthew R Broome7,8,9, Anthony A Grace10, Fernando Zelaya5, Philip McGuire2.   

Abstract

We recently reported that resting hippocampal, basal ganglia and midbrain perfusion is elevated in people at ultra high risk (UHR) for psychosis. The present study sought to replicate our previous finding in an independent UHR cohort, and examined the relationship between resting perfusion in these regions, psychosis and depression symptoms, and traumatic experiences in childhood. Pseudo-Continuous Arterial Spin Labelling (p-CASL) imaging was used to measure resting cerebral blood flow (rCBF) in 77 UHR for psychosis individuals and 25 healthy volunteers in a case-control design. UHR participants were recruited from clinical early detection services at 3 sites in the South of England. Symptoms levels were assessed using the Comprehensive Assessment of At Risk Mental States (CAARMS), the Hamilton Depression Scale (HAM-D), and childhood trauma was assessed retrospectively using the Childhood Trauma Questionnaire (CTQ). Right hippocampal and basal ganglia rCBF were significantly increased in UHR subjects compared to controls, partially replicating our previous finding in an independent cohort. In UHR participants, positive symptoms were positively correlated with rCBF in the right pallidum. CTQ scores were positively correlated with rCBF values in the bilateral hippocampus and negatively associated with rCBF in the left prefrontal cortex. Elevated resting hippocampal and basal ganglia activity appears to be a consistent finding in individuals at high risk for psychosis, consistent with data from preclinical models of the disorder. The association with childhood trauma suggests that its influence on the risk of psychosis may be mediated through an effect on hippocampal function.

Entities:  

Mesh:

Year:  2018        PMID: 29294102      PMCID: PMC6192497          DOI: 10.1093/schbul/sbx169

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  49 in total

1.  Spatiotemporal evolution of the functional magnetic resonance imaging response to ultrashort stimuli.

Authors:  Yoshiyuki Hirano; Bojana Stefanovic; Afonso C Silva
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yanjun Xu; Robert A Koeppe; Lisong Ni; Sally Guthrie; Edward F Domino
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

3.  Altered prefrontal and hippocampal function during verbal encoding and recognition in people with prodromal symptoms of psychosis.

Authors:  Paul Allen; Marc L Seal; Isabel Valli; Paolo Fusar-Poli; Cinzia Perlini; Fern Day; Stephen J Wood; Steven C Williams; Philip K McGuire
Journal:  Schizophr Bull       Date:  2009-11-23       Impact factor: 9.306

4.  Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography.

Authors:  Roy J Mathew; William H Wilson; Timothy G Turkington; Thomas C Hawk; R Edward Coleman; Timothy R DeGrado; James Provenzale
Journal:  Psychiatry Res       Date:  2002-12-30       Impact factor: 3.222

5.  Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.

Authors:  Paolo Fusar-Poli; Marco Cappucciati; Stefan Borgwardt; Scott W Woods; Jean Addington; Barnaby Nelson; Dorien H Nieman; Daniel R Stahl; Grazia Rutigliano; Anita Riecher-Rössler; Andor E Simon; Masafumi Mizuno; Tae Young Lee; Jun Soo Kwon; May M L Lam; Jesus Perez; Szabolcs Keri; Paul Amminger; Sibylle Metzler; Wolfram Kawohl; Wulf Rössler; Jimmy Lee; Javier Labad; Tim Ziermans; Suk Kyoon An; Chen-Chung Liu; Kristen A Woodberry; Amel Braham; Cheryl Corcoran; Patrick McGorry; Alison R Yung; Philip K McGuire
Journal:  JAMA Psychiatry       Date:  2016-02       Impact factor: 21.596

6.  Testing the psychosis continuum: differential impact of genetic and nongenetic risk factors and comorbid psychopathology across the entire spectrum of psychosis.

Authors:  Tolga Binbay; Marjan Drukker; Hayriye Elbi; Feride Aksu Tanık; Ferda Özkınay; Hüseyin Onay; Nesli Zağlı; Jim van Os; Köksal Alptekin
Journal:  Schizophr Bull       Date:  2011-04-27       Impact factor: 9.306

Review 7.  The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?

Authors:  Bill P Godsil; Janos P Kiss; Michael Spedding; Thérèse M Jay
Journal:  Eur Neuropsychopharmacol       Date:  2013-01-15       Impact factor: 4.600

8.  Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis.

Authors:  P Fusar-Poli; M Byrne; S Badger; L R Valmaggia; P K McGuire
Journal:  Eur Psychiatry       Date:  2012-11-06       Impact factor: 5.361

9.  Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain.

Authors:  Rowena Handley; Fernando O Zelaya; A A T Simone Reinders; Tiago Reis Marques; Mitul A Mehta; Ruth O'Gorman; David C Alsop; Heather Taylor; Atholl Johnston; Steve Williams; Philip McGuire; Carmine M Pariante; Shitij Kapur; Paola Dazzan
Journal:  Hum Brain Mapp       Date:  2012-03-25       Impact factor: 5.038

10.  Adversity in childhood linked to elevated striatal dopamine function in adulthood.

Authors:  Alice Egerton; Lucia R Valmaggia; Oliver D Howes; Fern Day; Christopher A Chaddock; Paul Allen; Toby T Winton-Brown; Michael A P Bloomfield; Sagnik Bhattacharyya; Jack Chilcott; Julia M Lappin; Robin M Murray; Philip McGuire
Journal:  Schizophr Res       Date:  2016-06-23       Impact factor: 4.939

View more
  26 in total

1.  Psychosis risk is associated with decreased white matter integrity in limbic network corticostriatal tracts.

Authors:  Kelsey T Straub; Jessica P Y Hua; Nicole R Karcher; John G Kerns
Journal:  Psychiatry Res Neuroimaging       Date:  2020-05-15       Impact factor: 2.376

2.  Heritability of Cerebral Blood Flow and the Correlation to Schizophrenia Spectrum Disorders: A Pseudo-continuous Arterial Spin Labeling Twin Study.

Authors:  Christian S Legind; Brian V Broberg; Rachel Brouwer; René C W Mandl; Bjørn H Ebdrup; Simon J Anhøj; Maria H Jensen; Rikke Hilker; Birgitte Fagerlund; Hilleke E Hulshoff Pol; Birte Y Glenthøj; Egill Rostrup
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

3.  Increased amplitude of hippocampal low frequency fluctuations in early psychosis: A two-year follow-up study.

Authors:  Maureen McHugo; Baxter P Rogers; Suzanne N Avery; Kristan Armstrong; Jennifer Urbano Blackford; Simon N Vandekar; Maxwell J Roeske; Neil D Woodward; Stephan Heckers
Journal:  Schizophr Res       Date:  2022-02-15       Impact factor: 4.939

4.  Predictive validity of conversion from the clinical high risk syndrome to frank psychosis.

Authors:  Laura A Yoviene Sykes; Maria Ferrara; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Daniel H Mathalon; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan; Kristen A Woodberry; Albert R Powers; Allison N Ponce; John D Cahill; Jessica M Pollard; Vinod H Srihari; Scott W Woods
Journal:  Schizophr Res       Date:  2019-12-19       Impact factor: 4.939

5.  Peripubertal mGluR2/3 Agonist Treatment Prevents Hippocampal Dysfunction and Dopamine System Hyperactivity in Adulthood in MAM Model of Schizophrenia.

Authors:  Susan F Sonnenschein; Anthony A Grace
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

6.  Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical Outcome.

Authors:  Gemma Modinos; Paul Allen; Andre Zugman; Danai Dima; Matilda Azis; Carly Samson; Ilaria Bonoldi; Beverly Quinn; George W G Gifford; Sophie E Smart; Mathilde Antoniades; Matthijs G Bossong; Matthew R Broome; Jesus Perez; Oliver D Howes; James M Stone; Anthony A Grace; Philip McGuire
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

7.  Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial.

Authors:  Sagnik Bhattacharyya; Robin Wilson; Elizabeth Appiah-Kusi; Aisling O'Neill; Michael Brammer; Jesus Perez; Robin Murray; Paul Allen; Matthijs G Bossong; Philip McGuire
Journal:  JAMA Psychiatry       Date:  2018-11-01       Impact factor: 21.596

Review 8.  Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.

Authors:  Susan F Sonnenschein; A Grace
Journal:  Expert Opin Ther Targets       Date:  2020-11-26       Impact factor: 6.902

Review 9.  Neuroimaging Markers of Resiliency in Youth at Clinical High Risk for Psychosis: A Qualitative Review.

Authors:  Teresa Vargas; Katherine S F Damme; Arielle Ered; Riley Capizzi; Isabelle Frosch; Lauren M Ellman; Vijay A Mittal
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-06-10

10.  Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.

Authors:  Gemma Modinos; Fatma Şimşek; Matilda Azis; Matthijs Bossong; Ilaria Bonoldi; Carly Samson; Beverly Quinn; Jesus Perez; Matthew R Broome; Fernando Zelaya; David J Lythgoe; Oliver D Howes; James M Stone; Anthony A Grace; Paul Allen; Philip McGuire
Journal:  Neuropsychopharmacology       Date:  2018-01-30       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.